Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
25,627
-3,756
-13% -$262K 0.01% 676
2025
Q4
$1.95M Buy
29,383
+3,501
+14% +$226K 0.01% 638
2025
Q3
$1.74M Sell
25,882
-1,870
-7% -$148K 0.01% 623
2025
Q2
$2.42M Sell
27,752
-6,617
-19% -$519K 0.01% 565
2025
Q1
$2.35M Sell
34,369
-3,411
-9% -$278K 0.01% 558
2024
Q4
$2.94M Buy
37,780
+937
+3% +$69.4K 0.01% 550
2024
Q3
$2.47M Sell
36,843
-11,189
-23% -$919K 0.01% 613
2024
Q2
$5.45M Buy
48,032
+4,444
+10% +$562K 0.02% 409
2024
Q1
$6.05M Buy
43,588
+7,662
+21% +$963K 0.02% 395
2023
Q4
$4.46M Sell
35,926
-1,046
-3% -$107K 0.02% 437
2023
Q3
$3.45M Sell
36,972
-1,865
-5% -$210K 0.01% 476
2023
Q2
$4.99M Sell
38,837
-1,059
-3% -$128K 0.02% 420
2023
Q1
$4.63M Buy
39,896
+1,269
+3% +$142K 0.02% 433
2022
Q4
$4.38M Sell
38,627
-842
-2% -$92.4K 0.02% 437
2022
Q3
$3.18M Buy
39,469
+3,205
+9% +$271K 0.01% 473
2022
Q2
$2.54M Buy
36,264
+676
+2% +$61.7K 0.01% 495
2022
Q1
$4.55M Buy
35,588
+4,064
+13% +$445K 0.02% 386
2021
Q4
$4.23M Buy
31,524
+136
+0.4% +$19.5K 0.02% 417
2021
Q3
$4.29M Sell
31,388
-3,144
-9% -$396K 0.02% 411
2021
Q2
$3.69M Sell
34,532
-3,036
-8% -$292K 0.02% 442
2021
Q1
$3.38M Sell
37,568
-2,076
-5% -$195K 0.01% 445
2020
Q4
$3.66M Buy
39,644
+3,552
+10% +$317K 0.02% 420
2020
Q3
$3.72M Sell
36,092
-424
-1% -$44.3K 0.02% 397
2020
Q2
$3.7M Sell
36,516
-6,468
-15% -$579K 0.02% 385
2020
Q1
$2.89M Buy
42,984
+6,960
+19% +$433K 0.02% 432
2019
Q4
$1.97M Buy
36,024
+264
+0.7% +$12.5K 0.01% 460
2019
Q3
$1.33M Sell
35,760
-1,084
-3% -$42.1K 0.01% 630
2019
Q2
$1.38M Sell
36,844
-12,732
-26% -$400K 0.01% 630
2019
Q1
$1.48M Buy
49,576
+36,324
+274% +$1.28M 0.01% 607
2018
Q4
$396K Sell
13,252
-5,764
-30% -$183K ﹤0.01% 1004
2018
Q3
$681K Buy
19,016
+540
+3% +$16.7K ﹤0.01% 892
2018
Q2
$439K Buy
18,476
+3,924
+27% +$83.2K ﹤0.01% 1071
2018
Q1
$269K Buy
+14,552
New +$215K ﹤0.01% 1272
2017
Q3
Sell
-45,456
Closed -$830K 1643
2017
Q2
$830K Sell
45,456
-1,680
-4% -$31K ﹤0.01% 814
2017
Q1
$998K Sell
47,136
-2,972
-6% -$58K 0.01% 751
2016
Q4
$748K Sell
50,108
-4,256
-8% -$75.4K ﹤0.01% 889
2016
Q3
$1.19M Buy
54,364
+39,276
+260% +$874K 0.01% 706
2016
Q2
$300K Sell
15,088
-5,452
-27% -$92.8K ﹤0.01% 1247
2016
Q1
$349K Sell
20,540
-13,896
-40% -$232K ﹤0.01% 1196
2015
Q4
$705K Sell
34,436
-852
-2% -$17.7K ﹤0.01% 938
2015
Q3
$758K Buy
35,288
+13,072
+59% +$292K 0.01% 908
2015
Q2
$444K Sell
22,216
-17,876
-45% -$314K ﹤0.01% 1281
2015
Q1
$625K Buy
40,092
+11,296
+39% +$171K ﹤0.01% 1074
2014
Q4
$397K Sell
28,796
-8,616
-23% -$105K ﹤0.01% 1321
2014
Q3
$374K Buy
+37,412
New +$382K ﹤0.01% 1412

Other funds holding DXCM

M&T Bank's DXCM Position: Q1 2026 in Review

M&T Bank reduced its DexCom (DXCM) stake by 13% in Q1 2026, selling an estimated $262K and leaving 25,627 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #676.

M&T Bank first reported a position in DXCM in Q3 2014 and has held it in 45 quarters since. The position peaked at $6.05M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • M&T Bank held 25,627 shares of DexCom worth $1.61M as of Q1 2026.
  • M&T Bank sold 3,756 DexCom shares in Q1 2026, an estimated $262K.
  • DexCom made up 0.01% of M&T Bank's portfolio in Q1 2026, its #676 holding.
  • M&T Bank first reported a position in DexCom in Q3 2014 and has held it in 45 quarters since.
  • M&T Bank's DexCom position peaked at $6.05M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.